Tatsis Ourania sold VRTX
February 18, 2025 · Form 4 insider transaction
Tatsis Ourania sold 244 shares of Vertex Pharmaceuticals Incorporated at $455.06 per share, a transaction worth $111.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
244
Price
$455.06
Total value
$111.0K
InsiderTatsis Ourania
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 18, 2025
Filing dateFebruary 19, 2025
Shares owned after67,695
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024.